Advertisement
Interim results of phase 2 trial are promising
Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes
Predictive tool should help in treatment decisions
A patient’s mental preparedness counts
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Method can eliminate need for liver biopsies in significant number of patients
Significant reduction in risk for vision loss and disease progression
An increasing variety of options can help more patients
Brillouin imaging, corneal cross-linking could aid identification and management of keratoconus and postoperative ectasia
Prospective review of parameters improves plan consistency, saves time
Speakers and topics for Booth 7125
Advertisement
Advertisement